Azasite - (1% Solution/Drops; Ophthalmic)

Generic Name	Azithromycin	Innovator	OAK Pharmaceuticals
Dosage	1% Solution/Drops; Ophthalmic	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	More Than 5	Tentative Approvals	Less Than 5
Final Approvals	None	Generic Launches	None
Indication	Used for the treatment of bacterial conjunctivitis
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
******	*** \ **	*** **, ****	*******	********* ********	****** **** ********
*****	** \ **	*** **, ****	*******	****	****** **** ********

Chronology Of Events